Colin Bristow

Stock Analyst at UBS

(0)
# 5051
Out of 5,441 analysts
103
Total ratings
Success rate
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
GILD Gilead Sciences
Maintains: Neutral
108 112
120.57 -7.11% 4 Aug 8, 2025
VRTX Vertex Pharmaceutica...
Maintains: Buy
582 553
374.47 47.68% 15 Aug 5, 2025
PTCT PTC Therapeutics
Maintains: Strong Buy
71 80
43.3 84.76% 4 Jul 29, 2025
RCKT Rocket Pharmaceutica...
Maintains: Buy
12 5
2.93 70.65% 3 Jun 17, 2025
ALXO ALX Oncology Holding...
Maintains: Buy
2 1
0.62 61.29% 6 May 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
38 17
14.76 15.18% 6 Apr 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
315 319
285.1 11.89% 9 Apr 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 4
1.41 183.69% 4 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
34 7
3.71 88.68% 2 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
29 28
24.61 13.77% 12 Feb 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
125 120
80.06 49.89% 6 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
234 202
128.03 57.78% 10 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
56 16
6.36 151.57% 5 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
1090 1099
546.18 101.22% 1 Apr 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
164 167
17.95 830.36% 5 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
428 420
635.48 -33.91% 1 Dec 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12 2
4.13 -51.57% 2 Dec 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
2.25 700% 1 Oct 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
154 146
198.62 -26.49% 2 Aug 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
73 75
45.94 63.26% 1 Jul 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
64 26
2.42 974.38% 1 Apr 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
6.21 44.93% 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
195
n/a n/a 2 Feb 1, 2021